Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07328425 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS

Study acronym: ISG-TULIPS
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 1 of 5 sitesv5
  2. Trial sites expanded: 1 → 5 locationsv4
  3. Study title expanded, about 11 wordsv3
  4. Interventions: Lurbinectedin and Irinotecan (Drug) to Irinotecan (Drug), Lurbinectedin (Drug)
    • Secondary endpoints revised (6)
    • Study description shortened, about 1 word
    • Study title shortened, about 5 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Italian Sarcoma Group
11 trials monitored
See 1 trial at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
Patients participating in this study have DSRCT that has spread locally or to other parts of the body and can no longer be surgically removed without causing significant harm. Treatment will continue until the tumor progresses further, severe side effects occur, or either patient or investigator decision. In addition, patients may participate in an optional biological study. The study will analyze the tumor's genes and the molecules related to them. By studying genes and their products, the investigators can better understand the behavior of the tumor and how the body responds to therapies.
Trial Details
NCT Number NCT07328425
Lead Sponsor Italian Sarcoma Group
Conditions
(from sponsor)		 Desmoplastic Small Round Cell Tumor
Related terms Desmoplastic Small Round Cell Tumor
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov